Hyperammonemia: Elevated ammonia levels in multiple myeloma [3]

American Journal of Medicine

Volumn 116, Issue 3, 2004, Pages 210-211

  Holahan, Joseph R ^a  

^a South Texas Gynecologic Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; DEXAMETHASONE; VINCRISTINE;

AGED; AMMONIA BLOOD LEVEL; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; GAMMOPATHY; HUMAN; HYPERAMMONEMIA; HYPERGAMMAGLOBULINEMIA; LETTER; LIVER FUNCTION; MEDICAL EXAMINATION; MULTIPLE MYELOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 1642512489     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.06.010     Document Type: Letter

References (8)

1. Caminal L., Castellanos E., Mateos V., et al. Hyperammonaemic encephalopathy as the presenting feature of IgD multiple myeloma. J Intern Med. 223:1993;227-229.
2. Matsuzaki H., Uchiba M., Yoshimura K., et al. Hyperammonaemia in multiple myeloma. Acta Hematol. 84:1990;130-134.
3. Perez Retortillo J.A., Marco F., Amutio E., et al. Hyperammonemic encephalopathy in multiple myeloma. Hematologica. 83:1998;956-957.
4. Martinelli G., Peccatori F., Ullrich B., et al. Clinical manifestation of severe hyperammonaemia in patients with multiple myeloma. Ann Oncol. 8:1997;811.
5. Matsuzaki H., Hata H., Sonoki T., et al. Serum amino acid disturbance in multiple myeloma with hyperammonemia. Int J Hematol. 61:1995;131-137.
6. Matsuzaki H., Matsuno F., Yoshida M., et al. Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma. Rinsho Ketsueki. 30:1989;361-365.
7. Matsuzaki H., Matsuno F., Yoshida M., et al. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia. Intern Med. 31:1992;339-343.
8. Kozuka T., Fukada S., Imai T., Sekaki T. Clinical significance of a multiple myeloma cell line derived from a case associated with hyperammonaemia. Rinsho Ketsueki. 41:2000;1220-1225.